Summit Therapeutics Inc. (SMMT) /
The profitability of Summit Therapeutics Inc. over the past 8 years
Chart Summit Therapeutics Inc.: operating income, net income, fiscal 2018–2025 Open the chart →Summit Therapeutics Inc. reported a net loss of $1.08B in fiscal 2025, the latest fiscal year on file. It reported a profit in 1 of the 8 years shown, and a loss in fiscal 2018, 2020, 2021, 2022, 2023, 2024 and 2025. Its highest net income in these years was $10.87M, in fiscal 2019.
Year by year
| Fiscal year | Operating income | Net income |
|---|---|---|
| 2025ended Dec 31, 2025 | — | -$1.08B |
| 2024ended Dec 31, 2024 | -$226M | -$221.31M |
| 2023ended Dec 31, 2023 | -$609.65M | -$614.93M |
| 2022ended Dec 31, 2022 | -$72.09M | -$78.78M |
| 2021ended Dec 31, 2021 | -$86.19M | -$88.6M |
| 2020ended Dec 31, 2020 | -$53.19M | -$52.7M |
| 2019ended Jan 31, 2019 | $5.39M | $10.87M |
| 2018ended Jan 31, 2018 | -$28.37M | -$26.35M |
Fiscal years as Summit Therapeutics Inc. reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on Summit Therapeutics Inc.
- The revenue of Summit Therapeutics Inc.
- The cash flow of Summit Therapeutics Inc.
- The debt of Summit Therapeutics Inc.
- All of Summit Therapeutics Inc.'s financials, charted
Companies of a similar size
- DVADAVITA INC.
- WTSWATTS WATER TECHNOLOGIES INC
- FDSFACTSET RESEARCH SYSTEMS INC.
- AITAPPLIED INDUSTRIAL TECHNOLOGIES, INC.
- ALLYAlly Financial Inc.
Not investment advice. This page shows what Summit Therapeutics Inc. filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.